Albumin Utilization Evaluation in a Teaching University Hospital in Iran

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 35

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PBRE-11-4_004

تاریخ نمایه سازی: 9 اسفند 1404

چکیده مقاله:

Background: Human albumin solution (HAS) is an expensive colloidal preparation that is commonly used in clinical practice. Given the high cost of albumin and its rising worldwide use, it is imperative to establish a practical protocol to improve the rational use of albumin products. This study aimed to identify albumin utilization patterns in a teaching hospital and to demonstrate the importance of revisiting strategies for albumin administration. Objectives: This study aimed to identify albumin utilization patterns in a teaching hospital and to demonstrate the importance of revisiting strategies for albumin administration. Methods: This retrospective study was conducted between March ۲۰, ۲۰۲۳, and March ۱۹, ۲۰۲۴, at Imam Khomeini Educational Hospital, an affiliated hospital of Mazandaran University of Medical Sciences, Sari City, Iran. All albumin forms completed during the study period were enrolled for appropriateness evaluation in accordance with the protocol developed by the Iranian Food and Drug Administration. Results: In ۸۲ patients (۳۲.۱%), serum albumin levels were greater than ۲.۵ g/dL at the time of albumin administration, of which ۵۶% were above the recommended cut-off for the indication. Among ۳۱۳ albumin prescriptions, in ۷ cases (۲.۳%), albumin administration was not based on any official indication listed in the protocol. Albumin level less than ۲.۵ g/dL for ۳ days (۲۵.۴%), ascites or generalized edema (۲۴.۴%), and hepatorenal syndrome (HRS) (۱۳%) were the most common reasons for albumin administration. The daily albumin dose ranged from ۱ vial of ۲۰% to ۵ vials, averaging ۱۹ g/d. Only one patient (۰.۳%) had the duration of albumin treatment stated, and no patient had their albumin levels rechecked ۷۲ hours after administration. Conclusion: This study showed significant deviations from the albumin prescription protocol. Some aspects of albumin prescribing, including the minimum cut-off for starting albumin, the duration of use, and rechecking the albumin level, were not adequately considered by physicians. These findings highlight a more sophisticated focus on albumin prescribing in an attempt to minimize the irrational prescription of this expensive and valuable drug.

نویسندگان

Ebrahim Salehifar

Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Institute of Herbal Medicines and Metabolic Disorders, Mazandaran University of Medical Sciences, Sari, Iran.

Zahra Bagherzadegan

Department of Pharmaceutical Care, Emam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.

Shahram Ala

Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Institute of Herbal Medicines and Metabolic Disorders, Mazandaran University of Medical Sciences, Sari, Iran.

Sima Ramezaninejad

Department of Clinical Pharmacy, School of Pharmacy, Babol University of Medical Sciences, Babol, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Caraceni P., Domenicali M., Tovoli A., Napoli L., Ricci C. ...
  • Bachhav SS, Kshirsagar NA. Systematic review of drug utilization studies ...
  • WHO. WHO medicines strategy: framework for action in essential drugs ...
  • Kazemi Y, Hadavand N, Hayatshahi A, et al. Albumin utilization ...
  • Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. ۱۹۸۸ ...
  • Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; ...
  • Khamas S. S., Mirbagheri I., Dehnadi-moghaddam A., Ashouri A. (۲۰۲۱). ...
  • Lyu P. F., Hockenberry J. M., Gaydos L. M., Howard ...
  • Noormandi A., Karimzadeh I., Mirjalili M., Khalili H. (۲۰۱۹). Clinical ...
  • Yu, Yue-Tian۱; Liu, Jiao۲; Hu, Bo۳; Wang, Rui-Lan۴; Yang, Xiang-Hong۵; ...
  • Margarson M, Soni N. Serum albumin: Touchstone or totem? Anaesthesia. ...
  • Aramwit P, Kasettratat N. Evaluation of serum albumin utilization in ...
  • Talasaz AH, Jahangard-Rafsanjani Z, Ziaie S, Fahimi F. Evaluation of ...
  • Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. ...
  • Abedi F, Zarei B, Elyasi S. Albumin: a comprehensive review ...
  • Jahangard‑Rafsanjani Z, Javadi MR, Torkamandi H, Alahyari S, Hajhossein Talasaz ...
  • Kazemi Y, Hadavand N, Hayatshahi A, Torkamandi H, Gholami K, ...
  • Shafiee E, Rezaee H, Entezari-Maleki T, Hamishehkar H. The evaluation ...
  • Farsad B., Hadavand N., Masumi S., Salehi H. (۲۰۱۶). Albumin ...
  • نمایش کامل مراجع